The U.S. Povidone market continued to strengthen during May 2026, following the bullish momentum established in April as elevated import costs, tight prompt availability, and resilient pharmaceutical demand supported higher CFR offers. Importers faced rising replacement costs for Povidone cargoes from China and Europe due to sustained freight expenses, controlled export allocations, and extended customs clearance timelines. Pharmaceutical and medical-device manufacturers remained the key demand drivers for Povidone, increasing procurement ahead of summer production cycles for antiseptic and healthcare formulations. Distributors also expanded safety-stock purchases after experiencing delayed replenishment schedules in April, further tightening spot availability across the U.S. market. Buyers increasingly prioritized supply security over aggressive negotiations, intensifying competition for limited Povidone cargoes. Supply conditions remained constrained amid disciplined pricing strategies from exporters and prolonged shipping lead times. Market participants now expect the Povidone market to maintain a firm near-term outlook, with prices projected to rise an additional 5–6% if freight and restocking pressures persist.
